An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Methylphenidate is the first-line pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD). Although methylphenidate has a well-established evidence base for treating ADHD, its long-term benefits are unclear. Areas covered: Physical adverse effects, psychiatric adverse events and brain development Expert opinion: Some physical adverse events have been described (e.g. sleep disturbances, growth reduction, loss of appetite), although most are of transient nature. Psychiatric adverse events seem more related to the diagnosis ADHD itself, and not stimulant treatment. Concluding, short-to-mid-term use (i.e., up to 2 years) stimulants are relatively safe, but much less is known about longer-term efficacy and safety of these drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Polanczyk, G. V., Salum, G. A., Sugaya, L. S., Caye, A., & Rohde, L. A. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12381 · Cited by 3,990 · cited 1×
“ADHD affects around 3% to 4% of children and adolescents [2] and often continues into adulthood [3] with rates in adulthood varying around 2.”
BackgroundPrevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082 · cited 1×
“substance use disorders (SUDs) in ADHD [74].”
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Nakao, T., Radua, J., Rubia, K., & Mataix-Cols, D. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020281 · Cited by 588
van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.007 · Cited by 535
Frodl, T., & Skokauskas, N. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01786.x · Cited by 530 · cited 1×
“nantly medication-naive individuals were included compared to when more previously treated individuals were included [94,95].”
BackgroundTreatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
Charach, A., Yeung, E., Climans, T., & Lillie, E. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.09.019 · Cited by 482
Research works printed but not linked: 5
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders [DSM-IV-TR]. Washington (DC): American Psychiatric Association; 2000.
- Storebo OJ, Ramstad E, Krogh HB, et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2015 Nov 25;(11):Cd009885. Epub 2015 Nov 26.
- Johnson MR. Increased cardiovascular risk associated with methylphenidate use in children and adolescents with ADHD? Examine the evidence. BMJ. 2016;353:i2550. [letter to the editor]
- 10.1001/jama.1976.03260390035024 · DOI
- 10.1176/appi.ajp.163.7.1149 · doi:10.1176/appi.ajp.163.7.1149 · Paper page
Cited by
Treatment strategies for ADHD: an evidence-based guide to select optimal treatment
Caye, A., Swanson, J. M., Coghill, D., & Rohde, L. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0116-3 · Cited by 303
Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts
Chang, Z., Quinn, P. D., O’Reilly, L. M., Sjölander, A., Hur, K., Gibbons, R. D., Larsson, H., & D'Onofrio, B. M. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.12.003 · Cited by 71
Pozzi, M., Carnovale, C., Peeters, G. G. A. M., Gentili, M., Antoniazzi, S., Radice, S., Clementi, E., & Nobile, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.021 · Cited by 56
Rosi, E., Grazioli, S., Villa, F. M., Mauri, M., Gazzola, E., Pozzi, M., Molteni, M., & Nobile, M. (2020) · Nutrients · doi:10.3390/nu12061573 · Cited by 27
Lionarons, J. M., Hellebrekers, D. M. J., Klinkenberg, S., Faber, C. G., Vles, J. S. H., & Hendriksen, J. G. M. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.09.005 · Cited by 23
Metadata
- Authors
- Groenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J.
- Affiliations
- University Medical Center Groningen (NL)
- University of Cambridge (GB)
- Corresponding author
- Groenman, Annabeth P.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2017-03-09
- Volume
- 16
- Issue
- 4
- Pages
- 455-464
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2592348399
- Cited by
- 46
- References
- 123
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 3
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- other-oa
- Locations
- Expert Opinion on Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- attention deficit hyperactivity disorder, methylphenidate, psychostimulants, drug safety, long-term efficacy, sleep disorders, growth reduction, appetite loss, psychiatric adverse events, brain development
- MeSH terms
- Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Brain, Humans, Methylphenidate, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder. https://app.cochat.ai/papers/10.1080/14740338.2017.1301928
- The paper
- Groenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J. (2017). An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2017.1301928
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.